Liu Yunhai Neurology


Specialty:Cerebrovascular diseases, epidemiological survey, acute thrombolysis, minimally invasive puncture treatment of cephalophyma, primary and secondary prevention of cerebral apoplexy.

Detailed introduction

Male, born in 1961, M.D. doctoral supervisor, professor /chief physician in neurology, deputy director of Institute of Neurology, Xiangya Hospital, Central South University and director of the cerebrovascular disease sub-specialty.


Social Appointments

Committee member, Cerebrovascular Disease Group, Neurological Professional Committee of Chinese Medical Association

Committee member, the Ministry of Health, the Expert Committees of High-Risk Population Screening and Prevention for Stroke

Vice-chairman, Hunan Provincial Professional Committee of Neurology

Deputy director, Hunan Provincial Quality Control Center for Stoke

Executive director, Hunan Provincial Prevention and Control Center of Cerebrovascular Disease 

Chairman, Hunan Provincial Cerebrovascular Disease Research Center



Sept.,1980-June,1985    Hunan Medical College, Bachelor Degree, Major in Clinic

Sept.,1989–June,1991   the First Affiliated Hospital of Hunan Medical University,

                                          Master Degree, Major in Neurology

Sept., 2002– June, 2005  Xiangya Hospital, Central South University,

                                            Doctor Degree, Major in Neurology 


Work Experience

July,1986-July,1996     the First Affiliated Hospital of Hunan Medical University

                                         Department of Neurology, Attending Doctor

July, 1997-July, 2002    Xiangya Hospital, Central South University,

                                         Department of Neurology, Associate professor

July, 2003 to now       Xiangya Hospital, Central South University,

                                      Department of Neurology, Professor


Scientific research

As project head and coordinator, Prof. Liu carried out several projects from Five-Year National Science and Technology Support Program (from 8th to 12th) , the National Nature Science Foundation, and from the natural science foundation of hunan province. According to the statistics, more than 150 papers have been published in recent years, including 12 SCI papers. So far, 4 students for M.D and 5 students for M.S. have graduated under his supervise.


Selected publications

1.Lingjuan Li,Geyue Qu, Mingyue Wang, Qing Huang, Yunhai Liu. Association of Oxysterol Binding Protein-Related Protein 9 Polymorphism with Cerebral Infarction in Hunan Han Population. Irish Journal of Medical Science.2013Nov5; DOI:10.1007/s11845-013-1035-6. 

2.Feng J, Liu YH, Yang QD, Zhu ZH, Xia K, Tan XL, Xia J, Gu WP, Zhou L, Xiao B, Tang BS, Huang Q. TNFSF4 gene polymorphism rs3861950 but not rs3850641 is associated with the risk of cerebral infarction in a Chinese population. J Thromb Thrombolysis. 2013,36:307-313    

3.Wang G, Su J, Li L, Feng J, Shi L, He W, Liu Y. Edaravone alleviates hypoxia-acidosis/ reoxygenation-induced neuronal injury by activating ERK1/2. Neurosci Lett. 2013 May 24;543: 72-7.                                              

4.Sun XG, Zhang N, Wang T, Liu YH, Yang QD, Jin X, Li LJ, Feng J. Public and professional education on urgent therapy for acute ischemic stroke: a community-based intervention in Changsha. Neurol Sci. 2013 Mar 17. [Epub ahead of print]     

5. X JIN, F ZENG, N ZHANG, T HUANG, Q MENG AND Y LIU. Association of Sterol  Regulatory Element-binding Transcription Factor Gene Polymorphisms with Ischemic Stroke. The Journal of Inter national Medical Research. 2012,40: 157 -166.               

6. Xin-Gang Sun, Yan-Li Wang, Yun-Hai Liu, Ning Zhang, Xiao-Ling Yin and Wen-Juan Zhang. Myasthenia gravis appearing after thymectomy. J Clin Neurosci,2011,18(1):57-60       

7. Liu YH, Tian T. Hypothesis of optineurin as a new common risk factor in normal-tension glaucoma and Alzheimer"s disease. Med Hypotheses. 2011,10;77(4):591-2.

8. Tian T, Liu YH. Normal-tension glaucoma and Alzheimer"s disease: retinal vessel signs as a possible common underlying risk factor.Med Hypotheses. 2011,9;77(3):466.

9. Tian Tian, Xiao-Hua Zhu, Yun-Hai Liu. Potential role of retina as a biomarker for progression of Parkinson"s disease. Int J Ophthalmo, 2011,Aug;4(4):433-438.



Research direction